·
Aurobindo gets final approval
for Omeprazole
Aurobindo Pharma
announced that the company has received the final approval from the US Food
& Drug Administration ( USFDA) to manufacture and market Omeprazole
Delayed-release Capsules USP, 10mg, 20mg and 40mg. The approved ANDA is
bioequivalent and therapeutically equivalent to the reference listed drug
product (RLD) Prilosec® Delayed-release Capsules, 10mg, 20mg and 40mg of
AstraZeneca Pharmaceuticals.
·
Aurobindo receives USFDA
approval for Ibandronate
Aurobindo Pharma
announced that the company has received final approvals from the US Food &
Drug Administration ( USFDA) to manufacture and market Ibandronate Sodium
Injection, 3mg/3mL (1mg/mL).
Ibandronate Sodium
Injection, 3mg/3mL (1mg/mL) is bioequivalent and therapeutically equivalent to
the reference listed drug product (RLD) Boniva® Injection, 3mg/3mL (1mg/mL) of
Hoffmann-La Roche, Inc. Ibandronate Sodium Injection is indicated for the
treatment of osteoporosis in postmenopausal women.
·
Crude oil declines further;
Brent at $47
Crude oil declined further; Brent at $47 and WTI at $ 40, new low - Positive
for OMC’s , Paints, Lubricants and Tyre companies .Crude Oil ( Brent) has
slipped again and is now trading below 5 year low at $ 46.92, while WTI Oil is
hovering around $40. As a result the industries which use crude and its
derivatives are expected to be beneficial. Positive for OMCs (HPCL, BPCL),
Paint (Asian Paints) and lubricants (Castrol, Gulf oil lubricant)
·
Lupin gets USFDA nod for
Fenofibrate tablets; stk jumps
Shares of Lupin
surged over 8%, touching to Rs1939.9, after pharma major said it has received
approval from USFDA for Fenofibrate tablets in dosages of 160 mg and 54 mg.
Fenofibrate is mainly used to reduce cholesterol levels in patients at risk of
cardiovascular disease. Like other fibrates, it reduces both low-density
lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as
increasing high-density lipoprotein (HDL) levels and reducing triglyceride
levels.
·
Ratnamani Metals bags new order
worth Rs159.40 cr
Ratnamani Metals
& Tubes has announced that the Company has bagged an order for supply of
coated CS pipes from Reliance Gas Pipelines amounting to Rs159.40 crores (net
of taxes and duties) to be completed in current financial year.
·
Somi Conveyor Beltings receives
orders worth Rs40.14 cr
Somi Conveyor
Beltings said that it has received purchase orders worth Rs40.137 crore from
BHEL, L&T and ThyssenKrupp Industries. The company will supply conveyor
belts and related material of various specifications, it said. The company has
bagged order worth Rs14.751 crore from Bharat Heavy Electricals ( BHEL). The
order worth Rs14.164 crore was received from Larsen & Tourbo ( L&T), it
said.
In addition,
ThyssenKrupp Industries India issued order worth Rs 11.222 million to the
company.
·
JSW Steel to invest Rs5000 cr
on capital expenditure
JSW Steel has said
that it is planning to invest about Rs5,000 crore on various capital
expenditure projects in this fiscal ending March 2016, as per reports.
Commenting on the issue, JSW Steel Chairman and Managing Director Sajjan Jindal
told the media, 'The company is expected to invest approximately Rs 5,000 crore
during FY16 on various capital expenditure programmes.'
·
Sun Pharma gets USFDA approval
for Ximino
Sun Pharma gets
USFDA approval for Ximino: Positive for the company .Sun Pharma gets US FDA
approval for Supplemental New Drug Application (sNDA) for Ximino. This approval
further strengthens the Company’s branded dermatology portfolio in the US. It
expects Ximino TM extended-release capsules to be available for patients during
the fourth quarter of 2015.
